Insulin and IGF-1 have significant implications in colon cancer development, as they activate the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway, stimulating cell growth and cell cycle signaling [31]. The gene discussed is AKT1; the disease is colonic neoplasm.